- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Disorders of Synovium, Multiple Sites
Total 26359 results
-
Novartis PharmaceuticalsCompletedMultiple SclerosisRussian Federation, Ukraine, Czech Republic
-
Isfahan University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
BiogenGB Pharma Services & Consulting s.r.l.Withdrawn
-
Rocky Mountain MS Research Group, LLCBiogenCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
Apitope Technology (Bristol) Ltd.Aptiv Solutions; ClinStar, LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom, Russian Federation
-
Neurotec PharmaAdvancell - Advanced In Vitro Cell Technologies, S.A.CompletedRelapsing Remitting Multiple SclerosisSpain, Germany
-
Tehran University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Anna TsakiriSanofiWithdrawnRelapsing Remitting Multiple SclerosisDenmark
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-remitting
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
University at BuffaloBiogenCompletedMultiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Bristol-Myers SquibbTerminated
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Remitting Multiple Sclerosis
-
Tehran University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Cantonal Hospital of St. GallenCompletedMultiple Sclerosis, Relapsing Remitting
-
Bayhill TherapeuticsCompletedRelapsing Remitting Multiple Sclerosis
-
St. Jude Children's Research HospitalTennessee Physical Therapy AssociationCompletedOsteosarcoma | Rhabdomyosarcoma | Synovial Sarcoma | Ewing's Sarcoma | Malignant Peripheral Nerve Sheath Sarcoma | Malignant Fibrous Histiocytoma of the Bone | Chondrosarcoma of the BoneUnited States
-
Sunnybrook Health Sciences CentreRecruitingMultiple Sclerosis | Major Depressive DisorderCanada
-
Meir Medical CenterUnknown
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple Sclerosis | Primary Progressive Multiple SclerosisSpain, United States, Italy, Poland, Turkey, New Zealand, Czechia, Brazil
-
SanofiRecruitingRelapsing Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisChina, Turkey, Korea, Republic of, United States, Ukraine
-
University Hospital, AntwerpHasselt University; University Hospital, Ghent; AZ Sint-Jan AV; National MS Center... and other collaboratorsRecruitingMultiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary-progressive Multiple SclerosisBelgium
-
Kessler FoundationKessler Institute for RehabilitationRecruitingMultiple Sclerosis | Cognitive Impairment | Gait Disorders, Neurologic | Motility DisorderUnited States
-
Dent Neuroscience Research CenterGenentech, Inc., a subsidiary of F. Hoffman-La Roche AG; Monogram Biosciences...Not yet recruitingMultiple Sclerosis | Relapsing Remitting Multiple Sclerosis
-
NHS Greater Glasgow and ClydeBiogenEnrolling by invitationRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Eisai Korea Inc.CompletedMultiple Sclerosis, Relapsing-remittingKorea, Republic of
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Argentina, Austria, Belgium, Croatia, Finland, France, Germany, Ireland, Italy, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey
-
BiocadCompleted
-
University at BuffaloWithdrawn
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal
-
Assistance Publique - Hôpitaux de ParisFondation ARSEP/AFMCompletedRelapsing Remitting Multiple SclerosisFrance
-
MSDx, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
OhioHealthCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Patient-Centered Outcomes Research Institute; Universita degli Studi di GenovaTerminatedRelapsing Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsCompleted
-
Isfahan University of Medical SciencesShiraz University of Medical SciencesCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisSpain, Australia
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark
-
Charite University, Berlin, GermanyBayerTerminatedRelapsing Remitting Multiple SclerosisGermany
-
BiogenCompletedRelapsing Remitting Multiple SclerosisGermany
-
GlaxoSmithKlineCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandNovartisCompletedRelapsing Remitting Multiple SclerosisSwitzerland
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States